These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1622162)

  • 1. Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis.
    Snydman DR; Cuchural GJ; McDermott L; Gill M
    Antimicrob Agents Chemother; 1992 Mar; 36(3):540-4. PubMed ID: 1622162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of agar dilution and broth microdilution by commercial and in-house plates for Bacteroides fragilis group: An economical and expeditious approach for resource-limited settings.
    Sood A; Angrup A; Ray P; Bala K
    Anaerobe; 2021 Oct; 71():102443. PubMed ID: 34492368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility results for the Bacteroides fragilis group: comparison of the broth microdilution and agar dilution methods.
    Hecht DW; Lederer L; Osmolski JR
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S342-5. PubMed ID: 7548593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
    Nagy E; Justesen US; Eitel Z; Urbán E;
    Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro antimicrobial susceptibilities of a special panel of 74 Bacteroides fragilis group isolates in Wilkins-Chalgren agar with and without sheep blood.
    Gill CJ; Shungu DL; Ponticas S
    Antimicrob Agents Chemother; 1989 Mar; 33(3):394-5. PubMed ID: 2729933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology.
    Aldridge KE; Wexler HM; Sanders CV; Finegold SM
    Antimicrob Agents Chemother; 1990 Jan; 34(1):179-81. PubMed ID: 2327757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of bacteroides fragilis group: effect of the medium on test results.
    Snydman DR; Jacobus NV; McDermott LA; Supran SE
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1710-2. PubMed ID: 10817736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of inoculum size and medium on activity of seven antimicrobial agents against Bacteroides fragilis strains.
    Wexler HM; Reeves D; Finegold SM
    Clin Ther; 1989; 11(6):828-33. PubMed ID: 2611824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics.
    Jorgensen JH; Redding JS; Howell AW
    J Clin Microbiol; 1986 Mar; 23(3):545-50. PubMed ID: 3514661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates.
    Aldridge KE; Sanders CV
    J Clin Microbiol; 1987 Dec; 25(12):2317-21. PubMed ID: 3480894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
    Goldstein EJ; Citron DM
    J Clin Microbiol; 1988 Nov; 26(11):2361-6. PubMed ID: 3235664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the E-test for susceptibility testing of the Bacteroides fragilis group. Danish study group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1994 Jun; 102(6):446-50. PubMed ID: 8068304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates.
    Bieluch VM; Cuchural GJ; Snydman DR; Gorbach SL; Tally FP
    Diagn Microbiol Infect Dis; 1987 Jun; 7(2):119-26. PubMed ID: 3652652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordant results between the broth disk elution and broth microdilution susceptibility tests with Bacteroides fragilis group isolates.
    Aldridge KE; Henderberg A; Schiro DD; Sanders CV
    J Clin Microbiol; 1990 Feb; 28(2):375-8. PubMed ID: 2312684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance profile of Bacteroides fragilis isolated in Brazil. Do they shelter the cfiA gene?
    das Graças Silva E Souza W; Avelar KE; Antunes LC; Lobo LA; Domingues RM; de Souza Ferreira MC
    J Antimicrob Chemother; 2000 Apr; 45(4):475-81. PubMed ID: 10747824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative effect of apalcillin and other beta-lactam antibiotics against the Bacteroides fragilis group].
    Dusart G; Simeon de Buochberg M; Zuccarelli M; Attisso MA; Willemin C
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):523-7. PubMed ID: 2797878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disk diffusion susceptibility testing of the Bacteroides fragilis group.
    Horn R; Bourgault AM; Lamothe F
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1596-9. PubMed ID: 3481247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
    Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns.
    Aldridge KE; Ashcraft D; O'Brien M; Sanders CV
    Antimicrob Agents Chemother; 2003 Jan; 47(1):148-53. PubMed ID: 12499183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of cefoxitin, cefotaxime alone, and in combination with desacetylcefotaxime against the Bacteroides species.
    Canawati HN
    Diagn Microbiol Infect Dis; 1989; 12(1):33-7. PubMed ID: 2714070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.